Paper Details

  1. Home
  2. Paper Details

Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation.

Author: EgererG, EhrhardI, GoldschmidtH, HaasR, HegenbartU, HoA D, SalwenderH

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Continuous infusion of ceftazidime was safe and effective in managing fever in neutropenic patients after high-dose chemotherapy and peripheral blood stem cell transplantation, allowing for outpatient treatment in most cases and reducing hospital costs.
Paper Details　
Original Abstract of the Article :
Neutropenia is an important complication of high-dose chemotherapy (HDCT). Neutropenic patients presenting with fever are routinely hospitalized for treatment with broad-spectrum antibiotics. Neutropenia up to 10 days is associated with a low-risk profile, and antimicrobial therapy administered on a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0924-8579(00)00155-2

データ提供：米国国立医学図書館（NLM）

Ceftazidime: A Reliable Oasis for Neutropenic Fever

Neutropenia, a condition that weakens the immune system and can make it vulnerable to infections, is a challenging complication of chemotherapy. This study investigates the efficacy of continuous ceftazidime infusion for treating neutropenic fever in patients who have undergone high-dose chemotherapy and peripheral blood stem cell transplantation.

A Safe Haven: Continuous Ceftazidime Infusion

The study found that continuous infusion of ceftazidime was effective in treating neutropenic fever in a significant proportion of patients, allowing for outpatient management in many cases. This is like finding a safe oasis in the desert, offering a refuge from the heat and providing a chance for the body to recover.

A Path to Recovery: Managing Neutropenic Fever Effectively

This research suggests that continuous ceftazidime infusion can be a valuable tool for managing neutropenic fever, potentially reducing the need for hospitalization and enabling a smoother recovery for patients. It's like providing a reliable caravan route, ensuring a safe and efficient journey through the challenging terrain of neutropenic fever.

Dr. Camel's Conclusion

This research highlights the effectiveness of continuous ceftazidime infusion in managing neutropenic fever, offering a potential oasis of relief for patients undergoing chemotherapy and stem cell transplantation. It's a testament to the enduring power of medicine to provide safe and effective treatment options for those facing difficult health challenges.
Date :
  1. Date Completed 2000-08-09
  2. Date Revised 2019-09-21
Further Info :

Pubmed ID

10854807

DOI: Digital Object Identifier

10.1016/s0924-8579(00)00155-2

Related Literature

Article Analysis
・Side Effects of imipenem
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.